BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38050369)

  • 1. Colloid Pattern of Salivary Mucinous Adenocarcinomas With Recurrent BRAF V600E Mutations.
    Zhang Y; Zhou Z; Liu X; Zhu L; Cui Y; Li TJ; Zhou CX
    Am J Surg Pathol; 2024 Mar; 48(3):266-274. PubMed ID: 38050369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Mucinous Adenocarcinoma Is a Histologically Diverse Single Entity With Recurrent AKT1 E17K Mutations: Clinicopathologic and Molecular Characterization With Proposal for a Unified Classification.
    Rooper LM; Argyris PP; Thompson LDR; Gagan J; Westra WH; Jordan RC; Koutlas IG; Bishop JA
    Am J Surg Pathol; 2021 Oct; 45(10):1337-1347. PubMed ID: 33739781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary gland papillary adenocarcinoma with intestinal-like features: Clinicopathologic, immunohistochemical, and genetic study of six cases.
    Liu X; Zhang Y; Zhou CX; Li TJ
    J Oral Pathol Med; 2022 Feb; 51(2):172-179. PubMed ID: 34982488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological evaluation of minor salivary gland papillary-cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm.
    Nakaguro M; Urano M; Ogawa I; Hirai H; Yamamoto Y; Yamaguchi H; Tanigawa M; Matsubayashi J; Hirano H; Shibahara J; Tada Y; Tsuzuki T; Okada Y; Sato Y; Ikeda K; Sukeda A; Honda Y; Mikami Y; Nagao T
    Histopathology; 2020 Feb; 76(3):411-422. PubMed ID: 31505033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.
    Ritterhouse LL; Vivero M; Mino-Kenudson M; Sholl LM; Iafrate AJ; Nardi V; Dong F
    Mod Pathol; 2017 Dec; 30(12):1720-1727. PubMed ID: 28776576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colloid (mucinous noncystic) carcinoma of the pancreas.
    Adsay NV; Pierson C; Sarkar F; Abrams J; Weaver D; Conlon KC; Brennan MF; Klimstra DS
    Am J Surg Pathol; 2001 Jan; 25(1):26-42. PubMed ID: 11145249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous carcinomas of the gallbladder: clinicopathologic analysis of 15 cases identified in 606 carcinomas.
    Dursun N; Escalona OT; Roa JC; Basturk O; Bagci P; Cakir A; Cheng J; Sarmiento J; Losada H; Kong SY; Ducato L; Goodman M; Adsay NV
    Arch Pathol Lab Med; 2012 Nov; 136(11):1347-58. PubMed ID: 23106580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
    Chen LF; Chen XY; Yu XB
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):221-5. PubMed ID: 27033383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
    Genova SN; Belovezhdov VT; Bichev SN; Danev VH
    Folia Med (Plovdiv); 2017 Jun; 59(2):174-182. PubMed ID: 28704186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations.
    Bishop JA; Nakaguro M; Whaley RD; Ogura K; Imai H; Laklouk I; Faquin WC; Sadow PM; Gagan J; Nagao T
    Histopathology; 2021 Sep; 79(3):338-346. PubMed ID: 33135196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.
    Skálová A; Hyrcza MD; Leivo I
    Head Neck Pathol; 2022 Mar; 16(1):40-53. PubMed ID: 35312980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. V600E BRAF versus Non-V600E BRAF Mutated Lung Adenocarcinomas: Cytomorphology, Histology, Coexistence of Other Driver Mutations and Patient Characteristics.
    Salimian KJ; Fazeli R; Zheng G; Ettinger D; Maleki Z
    Acta Cytol; 2018; 62(2):79-84. PubMed ID: 29320776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping clinicopathological entities within colorectal mucinous adenocarcinomas: a hierarchical clustering approach.
    Liddell C; Droy-Dupré L; Métairie S; Airaud F; Volteau C; Bezieau S; Laboisse CL; Mosnier JF
    Mod Pathol; 2017 Aug; 30(8):1177-1189. PubMed ID: 28429715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin-rich variant of salivary duct carcinoma: a clinicopathologic and immunohistochemical study of four cases.
    Simpson RH; Prasad AR; Lewis JE; Skálová A; David L
    Am J Surg Pathol; 2003 Aug; 27(8):1070-9. PubMed ID: 12883239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.
    Zenali MJ; Weissferdt A; Solis LM; Ali S; Tang X; Mehran RJ; Wistuba II; Moran CA; Kalhor N
    Hum Pathol; 2015 Jun; 46(6):836-42. PubMed ID: 25776025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
    Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
    Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialadenoma Papilliferum of the Bronchus: An Unrecognized Bronchial Counterpart of the Salivary Gland Tumor With Frequent BRAF V600E Mutations.
    Nakaguro M; Mino-Kenudson M; Urano M; Ogawa I; Honda Y; Hirai H; Tanigawa M; Sukeda A; Kajiwara N; Ohira T; Ikeda N; Mikami Y; Tada Y; Ikeda JI; Matsubayashi J; Faquin WC; Sadow PM; Nagao T
    Am J Surg Pathol; 2021 May; 45(5):662-671. PubMed ID: 33443864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma.
    Kakar S; Deng G; Smyrk TC; Cun L; Sahai V; Kim YS
    Mod Pathol; 2012 Jul; 25(7):1040-7. PubMed ID: 22522845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF V600E Mutations in Endometrial Adenocarcinoma.
    He M; Breese V; Hang S; Zhang C; Xiong J; Jackson C
    Diagn Mol Pathol; 2013 Mar; 22(1):35-40. PubMed ID: 23370429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.